Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-04
1993-07-06
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548183, A61K 31425
Patent
active
052254267
ABSTRACT:
A novel compound is proposed which is effective in curing various complications as with catarat, retinopathy, neurotic disorder, and renal disorder. The thiazolidine-2,4-dione compound represented by the following general formula I combines an action to inhibit aldose reductase and an action to depress blood sugar and manifests an efficacy in the cure of various complications as with catarat, retinopathy, neurotic disorder, and renal disorder. ##STR1## wherein R.sup.1 is a hydrogen atom or a methyl group.
REFERENCES:
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4725610 (1988-02-01), Meguro et al.
patent: 4948900 (1990-08-01), Iijima et al.
patent: 5061717 (1991-10-01), Clark et al.
Chemical Abstract vol. III, No. 23, Abstract No. 214230 to Chin et al.
Miyaoka Shozo
Sato Hiroko
Takahashi Hiroaki
Ushijima Hideto
Brust Joseph Paul
Gabilan Mary Susan H.
Terumo Kabushiki Kaisha
LandOfFree
Thiazolidine-2,4-dione compound and method of treatment of diabe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidine-2,4-dione compound and method of treatment of diabe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidine-2,4-dione compound and method of treatment of diabe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1689783